Navigation Links
Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
Date:8/14/2014

treatment of infectious diseases to be successfully developed or commercialized, Synthetic Biologics' inability to maintain its licensing agreements, or a failure by Synthetic Biologics or its strategic partners to successfully commercialize products and other factors described in Synthetic Biologics' report on Form 10-K for the year ended December 31, 2013 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

- Financial Tables Follow - Synthetic Biologics, Inc. and Subsidiaries(in thousands, except share and per share amounts)Condensed Consolidated Balance SheetsJune 30,December 31,20142013(Unaudited)(Audited)AssetsCash and cash equivalents

$
7,843
$
4,625
Prepaid expenses and other current assets

1,3891,591Property and equipment, net

5137Deposits and other assets

64Total Assets$
9,289
$
,257
Liabilities and EquityCurrent liabilities

$
,232
$
,027
Synthetic Biologics, Inc. and subsidiaries equity

8,05715,230Total Liabilities and Equity$
9,289
$
,257
 Condensed Consolidated Statements of OperationsFor the
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (Pertussis) at 54th ICAAC
2. Synthetic Biologics to Report Second Quarter 2014 Financial Results
3. Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile
4. Global Synthetic Biology Market 2014-2018
5. Synthetic Biologics to Present at the 7th Annual OneMedForum San Francisco 2014 Conference
6. Green Dot Develops Compostable Synthetic Leather Made with its Terratek® Flex Bioplastic
7. Synthetic Biologics Announces Exercise of Underwriters Over-Allotment Option
8. Synthetic Biologics Announces Proposed Public Offering of Common Stock
9. Global Geosynthetics Market 2012-2016
10. Process holds promise for production of synthetic gasoline
11. Startup to Strengthen Synthetic Biology and Regenerative Medicine Industries with Cutting Edge Cell Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 The North America Thermal ... market for detailed analysis of the growth trends ... reach $616.3 million by 2018, growing at a ... Browse through the TOC of the North America ... idea of the in-depth analysis and industry segmentation ...
(Date:11/26/2014)... , Nov. 26, 2014 The announced ... indicate the company is looking to expand in non-healthcare ... sales.  The healthcare market research firm says that  Siemens ... Kalorama Information,s biennial survey of the IVD market , ... any change in its composition would likely affect IVD ...
(Date:11/26/2014)... The Alliance for Safe Biologic ... European physicians at the "1 ST EuropaBio ... at the Spanish Ministry of Health, Social Services ... the Spanish Bioindustry Association (ASEBIO), included regulators from ... oncology and rheumatology societies, representatives from a hospital ...
(Date:11/26/2014)... November 26, 2014 The ETC ... award-winning technology innovation centers, announced today that applications ... on December 1st. “Do you have a big ... I want to know about it. AccelerateBaltimore helps ... to product in just 13 weeks.” Interested ...
Breaking Biology Technology:The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 2The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 3Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2ASBM Presents European Physicians Survey at Spanish Ministry of Health 2AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3
... Centers,of America, Inc. (Navitas), the market leader in ... to announce the,appointment of Dean H. Gesme, Jr., ... to currently providing care as a medical oncologist ... as the Past-Chair of the,National Coalition for Cancer ...
... Oct. 17 Monsanto Company (NYSE:,MON) today announced ... president and chief executive officer, and Robb Fraley, ... stock trading,plans in accordance with Rule 10b5-1 of ... plans, the Monsanto executives have directed brokers in ...
... Calif. and OSAKA, Japan, Oct. 17 Affymax,Inc. ... Limited (TSE: 4502),today announced that they have been ... Licensing Executives Society of the U.S. and Canada ... commercialize,Affymax,s lead product candidate, Hematide(TM), for the treatment ...
Cached Biology Technology:Navitas Names Dr. Dean Gesme as Medical Director 2Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia 2Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia 3
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock ... authentication solutions, and MorphoTrust USA (Safran), ... services, today announced a strategic partnership to offer ... motor vehicle administration (MVA), airport screening and financial ... identity-related solutions, MorphoTrust serves consumers through a nationwide ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... by Yale biologists, of the effects of 1997 El ... the Galpagos Islands, emphasizes the importance of studying populations ... and biological factors make specific populations more vulnerable than ... events provide an ideal system to study the impact ...
... describes hundreds of well-known and respected physicians, scientists, ... or advocated for homeopathic medicine. Eleven U.S. ... Charles Kettering, and C. Everett Koop are among ... benefited from homeopathy. Perhaps most surprisingly is the ...
... CHAMPAIGN, Ill. Using computer simulations, researchers at the University ... driving the molecule back and forth through a nanopore capacitor ... device that would read human genomes quickly and affordably., Being ... (which is the price most insurance companies are willing to ...
Cached Biology News:Global climate change: The impact of El Nio on Galpagos marine iguanas 2The surprising story of Charles Darwin and his homeopathic doctor 2The surprising story of Charles Darwin and his homeopathic doctor 3New technique could dramatically lower costs of DNA sequencing 2
... Invitrogens EvoQuest Services are ... prevail in the current competitive ... proprietary techniques to express, purify, ... your needs: Structure/Function Studies, Activity ...
... Standard Tray (3 per pack), 1. ... and blot processing.Automated staining of Coomassie ... and nucleic acid analysis.Prepares blots for ... detection.Programmable control of protocol, solution, volume, ...
... High quality kits and reagents ... give consistent and reliable 2-D ... up samples from contaminants.Efficiently dialyze ... protein for first-dimension isoelectric focusing.Reagents ...
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: